StonvexLoading…
StonvexStonvexStonvexCore line items from JBHT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.06B | $12.00B | $8.90B | $5.85B |
Operating Income | $207.05M | $865.07M | $618.61M | $375.95M |
Net Income | $141.55M | $598.28M | $417.21M | $246.36M |
EPS (Diluted) | $1.49 | $6.12 | $4.24 | $2.48 |
Total Assets | $7.93B | $7.93B | $8.11B | $8.24B |
Total Liabilities | Not available | $4.36B | Not available | Not available |
Cash & Equivalents | $4.56M | $17.28M | $52.29M | $50.90M |
Free Cash Flow OCF − CapEx | $242.77M | $947.59M | $696.31M | $343.95M |
Shares Outstanding | 95.20M | 94.59M | 98.42M | 99.23M |